Similarly, we showed that different B-cell malignancies including BL, MZL and DLBCL show high level of DEK expression in malignant B cells (Fig 4), which was similar to their normal counterpart (Fig 3B). This evidence concerns the gene DEK and Burkitt lymphoma.